Novartis “At An Inflection Point,” Announces $5B Buyback
In a move that reinforces its commitment to enhance returns to shareholders, Novartis AG (ADR) (NYSE:NVS) announced it will buy back shares worth $5B over the next two years, commencing immediately.
Novartis has reached an inflection point
"Novartis AG (ADR) (NYSE:NVS) has reached an inflection point, having fully integrated Alcon and reduced debt," said . . .
SORRY! This content is exclusively for paying members. If you are subscribed and having an account error please clear cache and cookies if that does not work email support@valuewalk.com or click Chat.
|
